Scarica l'app Stockscreener
1.63
1.24%
0.02
Dopo l'orario di chiusura:
1.62
-0.010
-0.61%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GERN Giù?
Forum
Previsione
Precedente Chiudi:
$1.61
Aprire:
$1.64
Volume 24 ore:
9.88M
Relative Volume:
1.04
Capitalizzazione di mercato:
$1.04B
Reddito:
$29.48M
Utile/perdita netta:
$-201.19M
Rapporto P/E:
-5.0938
EPS:
-0.32
Flusso di cassa netto:
$-216.50M
1 W Prestazione:
+11.64%
1M Prestazione:
+13.99%
6M Prestazione:
+20.74%
1 anno Prestazione:
-41.58%
Intervallo 1D:
$1.55
$1.6475
Intervallo di 1 settimana:
$1.46
$1.6899
Portata 52W:
$1.04
$2.835
Geron Corp Stock (GERN) Company Profile
Nome
Geron Corp
Settore
Industria
Telefono
(650) 473-7700
Indirizzo
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.63 | 1.03B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Sell |
| 2025-05-08 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-09 | Iniziato | Leerink Partners | Outperform |
| 2024-04-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Iniziato | TD Cowen | Buy |
| 2024-03-15 | Reiterato | Needham | Buy |
| 2023-09-12 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-03-28 | Iniziato | Goldman | Neutral |
| 2022-10-28 | Iniziato | Wedbush | Outperform |
| 2022-07-28 | Ripresa | B. Riley Securities | Buy |
| 2021-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2021-02-18 | Ripresa | B. Riley Securities | Buy |
| 2020-08-03 | Iniziato | Stifel | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Aggiornamento | Needham | Hold → Buy |
| 2019-01-31 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Reiterato | FBR & Co. | Outperform |
| 2016-09-13 | Reiterato | FBR Capital | Outperform |
| 2015-12-07 | Reiterato | Piper Jaffray | Overweight |
| 2015-04-21 | Iniziato | Oppenheimer | Outperform |
| 2014-06-12 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-12 | Downgrade | MLV & Co | Buy → Hold |
| 2013-12-10 | Reiterato | MLV & Co | Buy |
| 2013-12-10 | Aggiornamento | Needham | Hold → Buy |
| 2013-11-08 | Reiterato | MLV & Co | Buy |
| 2013-10-16 | Iniziato | MLV & Co | Buy |
| 2012-08-30 | Iniziato | Stifel Nicolaus | Buy |
| 2012-06-28 | Iniziato | Needham | Hold |
Mostra tutto
Geron Corp Borsa (GERN) Ultime notizie
Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Geron (NASDAQ:GERN) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Several Insiders Invested In Geron Flagging Positive News - Yahoo Finance
Geron Corporation Projects RYTELO Growth Amidst Revised Price Targets - StocksToTrade
Geron Corp Projects Major Revenue Boost for 2026 - StocksToTrade
Geron Corporation's (NASDAQ:GERN) Prospects Need A Boost To Lift Shares - simplywall.st
Geron (NASDAQ:GERN) Trading Up 8.4%Should You Buy? - MarketBeat
TD Cowen Revises Geron’s Price Target Amid RYTELO Expansion Plans - StocksToTrade
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
TD Cowen Maintains Buy Rating for Geron (GERN) While Trimming PT to $3 Ahead of Q4 Results - Finviz
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Geron Stock: Under-Promise And Over-Deliver Could Be The 2026 Strategy (GERN) - Seeking Alpha
Geron (NASDAQ:GERN) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Geron Corporation (NASDAQ:GERN) Nasdaq Index Clinical-Stage Biotech Profile - Kalkine Media
Geron Corporation (GERN) Eyes Profitability in 2026 amid Restructuring Drive - Insider Monkey
Geron Corporation (GERN) presents new data at the 67th American Society of Hematology 2025 annual meeting - MSN
HC Wainwright Predicts Geron's Q3 Earnings (NASDAQ:GERN) - MarketBeat
Geron Corporation (GERN) Streamlines Operations, Secures Financing, Eyes 2026 Growth - Finviz
What is HC Wainwright's Forecast for Geron FY2030 Earnings? - MarketBeat
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
Geron (NASDAQ:GERN) Stock Price Down 6.6%Here's Why - MarketBeat
Geron forecasts $220-240 million in RYTELO revenue for 2026 - Investing.com
Geron forecasts $220-240 million in RYTELO revenue for 2026 By Investing.com - Investing.com South Africa
Geron (GERN) Outlines Strategic Vision with FY26 Expense Forecas - GuruFocus
Geron (GERN) Forecasts Strong Revenue from RYTELO in 2026 - GuruFocus
Geron shares fall 7.5% premarket after 2026 revenue outlook falls short of estimate - marketscreener.com
Geron Corporation Provides 2026 Financial Guidance - TradingView
Geron Corporation (GERN) Stock Analysis: Exploring a 162.77% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Travel Stocks: What margin trends mean for Geron Corporation stockTrade Performance Summary & Technical Analysis for Trade Confirmation - Bộ Nội Vụ
What valuation multiples suggest for Geron Corporation stockJuly 2025 WrapUp & Reliable Intraday Trade Plans - ulpravda.ru
Will Geron Corporation stock benefit from infrastructure spending2025 Risk Factors & Low Drawdown Investment Ideas - ulpravda.ru
Geron (GERN) Plans Restructuring to Cut Costs, H.C. Wainwright Stays Neutral - Finviz
Geron Corporation Enters into Certain First Amendment to Loan Agreement with Biopharma Credit Investments V LP and BPCR Limited Partnership - marketscreener.com
Geron extends loan agreement deadlines for $250 million credit facility - Investing.com
Geron extends loan agreement deadlines for $250 million credit facility By Investing.com - Investing.com UK
Geron Signs Loan Agreement Amendment With BioPharma Credit - TradingView — Track All Markets
Geron Corporation (NASDAQ:GERN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Geron Stock Rallies More Than 60% in a Year: Here's Why - MSN
Geron (NASDAQ:GERN) Trading Up 4.9%Time to Buy? - MarketBeat
Geron Corporation (GERN) restructuring to lower operating expenses as it eyes profitability in 2026 - MSN
How Geron Corporation stock compares to market leadersJuly 2025 Price Swings & Precise Buy Zone Identification - Улправда
Can Geron Corporation (GON) stock expand revenue streamsWeekly Trade Report & Smart Investment Allocation Insights - Улправда
What margin trends mean for Geron Corporation stock2025 Volatility Report & Weekly High Potential Alerts - Улправда
Geron: From Launch Hype To Later-Line Gravity (NASDAQ:GERN) - Seeking Alpha
Geron (NASDAQ:GERN) Shares Down 3.9%What's Next? - MarketBeat
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Up 5.6%Here's What Happened - MarketBeat
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Geron Corp Azioni (GERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):